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Summary
18 cloned T cell lines reactive with Borrelia burgdorferi proteins, all CD3+4+8 -TCR-ot/0+ and
restricted byHLA class II proteins, were isolated from four patients with chronic Lyme arthritis .
Analysis of these T cell clones indicated that the T cell response to the Lyme disease spirochete
is not oligoclonally restricted ; yet all produced the same pattern of lymphokines, resembling
that ofmurine type 1 T helper cells, after antigen-specific or nonspecific stimulation . Therefore,
a subset ofhuman CD4+ T cells, with a distinct profile of lymphokine secretion, is selectively
activated by the pathogen inciting this chronic inflammatory disease.
A nalysis of experimental animal models (1, 2), as well as
more limited data on certainhuman inflammatory dis-
eases (3, 4), has emphasized the involvement of T cells ex-
pressing a restricted set ofTCR variable region genes in the
pathogenesis of inflammatory disease. The assumption un-
derlying this paradigm is that the selective clonal expansion
ofT lymphocytes leads to inflammatory disease. An impor-
tant corollary to this theory is that the TCR expressed on
the pathogenic subset ofT cells provides a specific target for
pharmacologic treatment of the inflammatory disease (reviewed
in references 5 and 6) . The ability ofTCRspecific reagents,
including mAbs binding a particularTCR V/3 region (2, 7)
or nonstimulatory MHC-binding peptides (8, 9), to prevent
the induction of a prototypic T cell-mediated autoimmune
disease, murine experimental allergic encephalomyelitis, pro-
vides in vivo experimental support for this theory.
In contrast to many models, Lyme disease serves as a unique
clinical entity for studying the molecular and cellular mech-
anisms underlyinghuman chronic inflammatory disease, since
the tick-borne spirochete, Borrelia burgdorferi, causing Lyme
disease has been identified (10) and can be cultured in vitro
(11) . A subset ofpatients withLyme disease develop a chronic
inflammatory arthritis that resembles other forms ofhuman
inflammatory arthritis, including rheumatoid arthritis (12,
13) . Characterization of cloned T cell lines reactive with the
inciting spirochetal pathogen may therefore provide insight
into the role that T cells play in the pathogenesis ofLyme
disease and other inflammatory disorders . Accordingly, we
have extensively analyzed the functional properties, including
the pattern of lymphokine production of 18 Borrelia-reactive
T'cell clones isolated from four patients withLyme arthritis .
Materials and Methods
B burgdorferi Antigen and Purred Proteins.
￿
The CA12 isolate
ofB burgdorferi was cultured in BSKII medium, harvested, and a
sonicate was prepared for use in cellular proliferation assays as pre-
viouslydescribed (14) . The proteins in theB burgdorferi lysate were
separated by SDS-PAGE and purified proteins, or groups of pro-
teins, were prepared by electroelution from gel slices as previously
described (14, 15). Treponemaphagedenis biotype Reiter was obtained
from Dr. JamesM . Miller (UCLA) and was grown in BBL spiro-
late broth (Becton Dickinson Microbiology Systems, Cockeysville,
MD) . A sonicate of this spirochete was prepared for use in cellular
proliferation assays, as described for B burgdorferi .
Preparation ofClonedT Cells andB Lymphoblastoid Cell Lines.
￿
The
clinical histories of the four patients with chronic Lyme arthritis
(CR, AP, GN and SS) used in this study have been previously de-
scribed (14, 15) . Cloned T cell lines reactive with B burgdorferi an-
tigens were isolated from PBMC or synovial fluid cells (SFC)' ob-
tained from these four patients, as previously described (14, 15).
In brief, 106 PBMC or SFC were stimulated with 50 pg/ml of
spirochetal antigen in 24-well tissue culture plates. After 7-10 d,
the growing T cell cultures were cloned by limiting dilution in
the presence ofa feeder mixture consisting ofirradiated (4,000rad)
autologousPBMC, the lymphoblastoid cell lineJY, andPHA (Well-
come, Beckenham, UK) . Alloreactive and tetanus toxin-specific
T cell clones were generated by incubation of 101 PBMC from
healthy donors or Lyme arthritis patients with 2 x 105 JY cells
or i Rg/ml tetanus toxin (Dr. Bizzini, Institute Pasteur, Paris,
France), respectively . After 7-10 d, growing T cells were cloned,
as described above. 14-20 d after cloning, growing cultures were
transferred, then re-stimulated every 14 d with the feeder cell mix-
ture described above, and expanded with medium containing 20
i Abbreviation used in this paper. SFC, synovial fluid cells .
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pared from each patient by in vitro infection with EBV (14) . All
cloned T cell lines and lymphoblastoid B cell lines were cultured
in Yssel's medium (14) supplemented with 1% AB+ human
serum.
Analysis ofthe Cloned TCells.
￿
Cellular proliferation was mea-
sured using a 72-h [311]thymidine assay, with autologous B lym-
phoblastoid cells as APC, as described previously (14) . Whole
B. burgdorferi sonicate, gel-purified spirochetal protein fractions, or
lysates ofEscherichia coli expressing recombinant proteins were used
as antigen . To study the inhibitory effects ofanti-HLA mAbs, the
APC were incubated at room temperature with dilutions of anti-
HLA-DR (Q5/13) or anti-HLA-DQ (SPVL3) mAbs for 20 min
before the assay.
Analysis of cells for the expression of cell surface antigens was
performed by flow cytometry using a FACScan® (Becton Dick-
inson & Co ., Mountain View, CA), as previously described (14) .
mAbs against the following antigens indicated in parentheses were
used : 6G4 (CD2), RIV6 (CD4), SPVT3b (CD3), SPVT8 (CD8),
BF1 (TCR-a/(3 ; T Cell Sciences, Cambridge, MA), and TCR61
(TCR S chain) .
The lytic activity of theT cell clones was measured usinga4-h
"Cr release assay as previously described (14) . The target cells were
pulsed with antigen for at least 4 h and were washed at least three
times with medium before labeling with "Cr .
HLA Phenotyping.
￿
The HLA phenotype of the patients was
determined by the Stanford University Hospital tissue typing lab-
oratory. TheHLA types ofBlymphoblastoid cell lines used to iden-
tify the HLA elements involved in the recognition of spirochetal
antigen were as follows: GNE, A2/10,B39/(5?15)(W6),DR6/wll
(w52),DQw1w3 ; APT,DR3/w6 (w52), DQwl,w2;CAC-A1/x,
B8/51, Cw7, DR2/5, DQwl/w3; CNR, DR2/2, wl, wl ; SNS,
DR2/w6(w52), DQwl/w3; RIG-DR2/4(w53), DQwl/w3;
NPR, A2/10,B18/39,DRwll, DQw3 ; CAD DR7/7, DQw2/2 ;
JY, A2/-,B7/-,DR4/6 ; and HSY, Al/w19,B8/13, DR3/7 .
Lymphokine Assays.
￿
Lymphokine-containing supernatants were
prepared from cloned T cells stimulated with spirochetal antigen
presented by autologous APC or 10 ug/ml Con A for 12-18 h,
as described (14) . The amount of 11,2 in the culture supernatants
wasdetermined using the I1,2-dependent murine CTLIr2 cell line
(16) . The amount of ILA (17), IL5 (18), granulocyte/macrophage
(GM)-CSF (18), IFN- ,y (19), and TNF-a (T cell Sciences) in the
culture supernatants wasdetermined using cytokine-specificELISAs .
Detectable levels ofcytokines were not produced by anyofthe cloned
T cell lines in the absence of stimulation . The values indicated are
the average of assays performed on two aliquots harvested from
a single supernatant . Similar results were obtained from indepen-
dently prepared supernatants harvested on different days .
Preparation ofExpressed RecombinantB . burgdoferi Proteins.
￿
The
OspA and OspB genes were isolated from plasmids pTRH44 and
pTRH46, respectively, which previously have been shown to en-
code these two spirochetal outer surface proteins (20, 21), byPCR
amplification . Amplifications were performed using the following
pairs of oligonucleotide primers : OspAl GGCCCCGGGAT
GAAAAAATATTTATTGGGAATA (sense), OspA2 GGCCCC-
GGGTTATTATTTTAAAGCGTTTTTAATTTC (anti-sense),
OspB3 (sense), GGCGAA TTCATGAGATTATTAATAGGATTT
GC OspB4 (antisense), GGCGTCGACTTATTATTTTAAAGC-
GTTTTTAAGCTC . The PCR amplification, cloning into a pro-
caryotic expression plasmid, and preparation of protein lysateswas
performed as previously described (22) . The preparation ofexpressed
recombinantHSP60 (15) and flagellar proteins (22) ofB. burgdorferi
have previously been described .
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Immunoblotting.
￿
One-dimensionalSDS-PAGE separationofpro-
teins, transfer to nitrocellulose, andimmunoblotting, using a 1:100
dilution of preabsorbed patient or control sera, was performed as
previously described (15) . Monoclonal anti-OspA (115332), anti-
OspB (116831), and anti-flagellan (119724) antibodies were . used
as 1:20 dilutions of culture supernatants supplied by Dr. A. Bar-
bour (University of Texas, San Antonio) . Control sera were pre-
pared from blood obtained from healthy individuals, 23-45 yr of
age, residing in Northern California, without a history of tick bite,
skin rash consistent with erythema migrans, arthritis, neurologic
disease, or other symptoms of Lyme disease.
TCR Variable Region Gene Utilization .
￿
RNAwas extractedfrom
5 x 106 cells of a cloned T cell line and was reversed transcribed
using oligo(dT) . The resulting cDNA wasPCR amplified using
a pair ofoligonucleotide primers ; a 5'-sense oligonucleotide specific
for each ofthe 18 Va (23) or 20 V(3 (24) subfamilies, and acommon
Ca or C/3 3'-antisense oligonucleotide. TheVa or V0 gene seg-
ment expressedwas identified by the presence ofa200-400-bp band
on an agarose gel visualized by ethidium bromide staining . For each
T cellclone analyzed, only oneVa- or VS-specific oligonucleotide
primer produced a detectablePCRamplifiedDNA segment. Iden-
tical results were obtained with different aliquots of each sample .
T cell clone GN12 was the only exception; both V03- and V/35 .1-
specific primers produced amplified products ofthe appropriate size .
Although we can not exclude the possibility that thisT cell clone
is not of monoclonal origin, the expression of a single Vce gene
product makes it is more likely that this is due to amplification
of thesame V(3 gene segmentby two different primers . To confirm
that theTCR (3 chain variable region.gene segmentwas correctly
identified by this technique, thecDNA encoding this protein was
isolated from one of the T cell clones . Analysis of the sequence
of the cDNA prepared from GN30 indicated that its variable re-
gion was encoded by the V(66.2 gene segment, consistent with
the PCRdetermination that its variable region was V06 (data not
shown) .
Results
R burgdorferi-specific CD4+ T Cell Clones.
￿
The T cell
clones described in this studyhave beenshown to specifically
recognize B . burgdorferi antigens; control antigens includ-
ing tetanus toxin and purified protein derivative (PPD), as
well as lysates of other bacteria, includingE. coli and the re-
lated spirochete, Treponema phagedenis, failed to trigger pro-
liferative responses (14, 15). The surfacephenotype of all of
these cloned T cells was CD4+8-TCRa/a+ . Although
CD4-8+ TCRa/a+ T cell clones were isolated, none of
them reacted with spirochetal antigens (data not shown) .
However, twoCD4+ T cell clones, GN30 (14) and CR238,
exhibited HLA-DRrestricted lysis of spirochetal antigen-
pulsed Blymphoblastoid cells (Fig. 1) . Thecytotoxic activi-
ties ofGN30 and CR238 were restricted byHLADRw11
and HLADR2, respectively, and were absent if the target
cells had not been pulsed with spirochetal antigen .
Identification of Spirochetal Antigens Recognized by R burg-
dorferi-speck T Cell Clones. The proteins in a lysate of
B, burgdorferi were fractionated by SDS-PAGE, andindividual
proteins or groups ofproteins of similar molecular mass were
purified by electroelution from polyacrylamide gel slices . The
ability of these purified proteins to induce a proliferative re-m
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￿
The cytolytic activity ofT cell clone CR238 . The lysis by
CR238 of 103 CNR, SNS, JY, or GNE B lymphoblastoid cells pulsed
with R burgdorferi antigen or nonantigen-pulsed control cells, was mea-
sured in a s1Cr release assay. Each data point represents the mean of tripli-
cate determinations, and the SD for each data point is <10%.
sponse by the spirochete-reactive T cell clones was measured.
The majority of the cloned T cells recognized one of the fol-
lowing purified spirochetal proteins or protein fractions : 30,
41, 42-55, 50-55, and 55-70 kD (Table 1) . However, four
T cell clones proliferated in response to an antigen in the
Borrelia sonicate, but not in response to any of the purified
proteins mentioned above. These four clones may recognize
antigens whose molecular mass is >70 kD, which are not
efficiently isolated using our procedure. These results reveal
that there is a diverse array ofspirochetal proteins recognized
by this panel of cloned human T cells.
When possible, the antigenic specificity of a T cell clone
was confirmed by measuring its proliferative activity in re-
sponse to stimulation with recombinant spirochetal proteins
expressed in E. coli. Toward this end, procaryotic expression
plasmids encoding the B. burgdorferi outer surface proteins
A and B (OspA and OspB), flagellin, and HSP60 were pre-
pared . The identity of the expressed recombinant OspA and
OspB was confirmed by immunoblot analysis using mAbs
specific for each protein (Fig . 2) . T cell clones AP75, AP141,
CR378, and CR380 were found to specifically recognize
recombinant OspA (Fig . 3) . Although AP74 proliferated in
response to a protein fraction with a molecular mass of 30-33
kD, which contains both outer surface proteins, it did not
recognize recombinant OspA or OspB (data not shown) . T
cell clone CR253 has previously been shown to recognize
an epitope located between amino acids 260-274 ofthe recom-
binant spirochetal 60-kD heat shock protein expressed inE. coli
(15) . None of the other T cell clones was found to recognize
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Characterization of Borrelia-reactive T Cell Clones
Isolatedfrom Four Patients with Chronic Lyme Arthritis
The TCR variable region genes expressed by the cloned T cells, the
spirochetal antigens recognized, as well as the HLA class II molecules
involved in antigen recognition were identified as described in Materials
and Methods .
" Reactive with Borrelia lysate, but not with purified protein .
t Indicates not amplified using primers for Val-18 or Vß1-20 .
S Reactive with expressed recombinant protein.
any of the available recombinant spirochetal proteins . Taken
together, these results reveal that there is a diverse array of
spirochetal proteins recognized by this panel of cloned human
T ells .
Diversity in theHLA Restriction Elements and 11CR Variable
Region Gene Usage by the Spirochete-reactive T Cell Clones. The
HLA restriction elements involved in the recognition of
R burgdorferi antigens by these cloned T cell lines are shown
in Table 1 . They were determined by measurement of the
proliferative responses of the T cell clones to spirochetal an-
tigens either presented by autologous APC in the presence
ofmAbs against HLA class II proteins, or using APCs that
express different HLA class II molecules . As shown in Table
1, differentHLA class II molecules are involved in the recog-
nition of spirochetal antigens by the T cell clones isolated
from the four patients . It is noteworthy that the proliferative
responses of different T cell clones isolated from the same
individual were restricted by distinct HLA-DR or DQ
specificities. Furthermore, T cell clones AP75 and AP141,
isolated from the same patient, recognized the same spirochetal
antigen in the context of different HLA class II molecules.
Clone Va va HLA-RE Bb Ag Source
GN12 2 3/5.1 DRw11 50-55 kD SFC
GN30 8 6 DRw11 41 kD SFC
GN348 15 6 DRw11 Bb lysate* PBMC
GN351 15 6 DRw11 Bb lysate* PBMC
CR238 # 9 DR2 Bb lysate* PBMC
CR253 1 3 DR2 HSP60S PBMC
CR329 8 4 DQwI 55-70 kD PBMC
CR378 6 5.1 DQS OspAs PBMC
CR380 t 13.1 DR2 OsPAS PBMC
SS7 8 9 DR2 55-70 kD PBMC
SS10 10 9 DR2 No data PBMC
SS13 8 9 DR2 55-70 kD PBMC
SS27 8 9 DR2 55-70 kD PBMC
AP56 8 20 Bb lysate* PBMC
AP74 5 2 DR6 30 kD PBMC
AP75 5 1 DR3 OspAs PBMC
AP97 3 6 42-55 kD PBMC
AP141 t t DR6 OspAs PBMCFigure 2 .
￿
Immunoblot analysis of antibody reactivity with expressed
recombinant E burgdorferiOspA and OspB.A coomassie blue-stained 10%
SDS-PAGE gel of protein lysates prepared fromE. coli transformed with
a control plasmid (Ec), or with the plasmids encoding OspA and OspB;
and B. burgdorferi (Bb) is shown. Immunoblotting was performed with
murine monoclonal anti-OspA (H5332), anti-OspB (H6831), and anti-
flagellin (H9724) antibodies. Arrowheads indicate the position of the ex- .
pressed recombinant outer surface proteins . Molecular mass markers (in
W) are indicated to the left .
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TCR Vci and V/3 gene segments expressed by the Borrelia-
reactive T cell clones were examined by PCR amplification
using Vot- and Vii-specific oligonucleotide primers . This al-
lowed us to determine if there was restricted TCRV region
gene usage among the T cells responding to spirochetal an-
tigens . This analysis indicates that a wide array of Vot and
VO gene segments were used to form theTCRs ofthe Borrelia-
reactive T cell clones (Fig. 4, Table 1) . For three of the four
patients examined, theTCR ofdifferent T cell clones, though
isolated from the same patient, utilized different V region
gene segments. T cell clones obtained from patient SS were
the exception; three of the four T cell clones appeared to be
daughter colonies derived from the same parental T cell .
Spirochete-reactive TCells Produce a Specific Pattern ofLym-
phokines . To analyze their profile of cytokine production,
the B . burgdorferi-reactive T cell clones were stimulated with
Con A or spirochetal antigen in the presence of APC . De-
spite the fact that they recognized different spirochetal an-
tigens and expressed distinct TCRs, all of the cloned Borrelia-
reactive T cell lines had a pattern of lymphokine secretion
resembling that of murine Thl cells . All T cell clones pro-
duced IL-2 (not shown), GM-CSF, TNF-a, and IFN--y upon
stimulation with spirochetal antigen orConA (Table 2). How-
ever, either mode of activation repeatedly failed to induce the
production of detectable levels of 11,3 (not shown), 114, or
IL-5, indicating that this lymphokine production profile is
an intrinsic property of these T cell clones. To determine
whether the Thl-like pattern of lymphokine secretion was
specific for the spirochete-reactive T cell clones, we analyzed
the cytokine production levels by tetanus toxoid-specific T
cell clones derived from Lyme arthritis patient CR. Upon
$- Bb
rOspA
- Ec
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T
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Figure 3 .
￿
The proliferative responses
ofT cell clones AP75, AP141, CR378,
and CR380 to serial dilutions of pro-
tein lysates ofR burgdorferi (Bb), and
E. toll transformed with control plasmid
(Ec) or with the plasmid encoding
spirochetal OspA (OspA). Each data
point represents the mean of triplicate
determinations, and the SDfor each data
point is <10% .Table 2 .
￿
Lymphokine Production by Borrelia-reactive T Cell
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Figure 4.
￿
Identification ofTCR vari-
able region genes expressed by T cell
clones CR378 and AP75 . cDNA pre-
pared from T cell clones CR378 and
AP75 was amplified by PCR using
TCR We- and V(3specific oligonucle-
otide primers. PCRamplifications were
initially performed using pooled
primers, each pool containing four or
five different Vxx- or VOspecific 5'-sense
oligonucleotides and a single CO an-
tisense oligonucleotide (pools 1-4) . To
identify theTCR variable region gene
segments utilized by theT cell clones,
PCR amplifications were performed
using the Vcx- or V/3specific oligonu-
cleotide primers found in the positive
pool. The expressed Va or Vii gene
segmentwas identified by the presence
of a 200-400-bp band on the agarose
gel visualized by ethidium bromide
staining.
Lymphokine-containing supernatants were prepared from cloned T cells stimulated with spirochetal antigen presented by autologous APC or 10
Wg/ml ConAfor 12-18 h . Lymphokine production was quantitated using the IL-2-dependent murine CTLL-2 cell line for IL-2, or cytokine-specific
ELISAs for IL-4, IL-5, GM-CSF, IFN-y, and TNF-a, as described in Materials and Methods . None of the cloned T cell lines produced any of the
cytokines in the absence of stimulation . Each data point is the average of duplicate determinations performed on single supernatant . Similar results
were obtained using three independently prepared supernatants .
Clone Bb
IL-4
Con A Bb
IL-5
Con A Bb
IFN-y
Con A Bb
GM-CSF
Con A
TNF-a
Bb Con A
pg/ml pg/ml pg/ml ng/ml pglml
CR238 <50 <50 <50 <50 12.4 17.3 1.2 4.3 260 5,675
CR253 <50 <50 <50 <50 <0.4 5.7 2 .0 4.6 630 1,535
CR329 <50 <50 <50 <50 3.6 20.4 2 .1 7.7 495 3,460
CR378 <50 <50 <50 <50 4.2 12 .3 6 .3 14.4 4,425 4,155
CR380 <50 <50 <50 <50 7.1 25 .5 1 .9 18.7 5,085 5,770
AP56 <50 <50 <50 <50 4.7 15 .9 3 .1 7.8 ND 1,810
AP74 <50 <50 <50 <50 49.5 52 .7 4.3 5.0 2,565 2,780
AP75 <50 <50 <50 <50 5.0 12 .5 2 .1 5.6 20 3,040
AP97 <50 <50 <50 <50 2.0 3 .3 ND ND 20 500
AP141 <50 <50 <50 <50 42.6 »60 3.6 3.1 1,750 1,955
GN12 <50 <50 <50 <50 8.0 >60 1 .0 >60 2,217 >3,000
GN30 <50 <50 <50 <50 14.2 »60 2.2 >60 >3,000 >3,000
GN348 <50 <50 <50 <50 1.0 >60 0.5 12.5 606 2,302
GN351 <50 <50 <50 <50 2.0 50 0.6 14.0 986 2,143activation, these T cell clones were found to produce 11,4
and IM (Table 3) . In addition, identical procedures have been
used to generate cloned T cell lines from healthy individuals
reactive with tetanus toxin or alloantigen. These T cell clones
were found to produce both IIr4 and IFN-'y upon activation
at levels ranging from 0.1-9 ng/ml and 1-60 ng/ml, respec-
tively (Table 3) . None ofthese T cell clones failed to produce
either of these cytokines.
Discussion
In this study we describe the functional characterization
of cloned T cell lines specific for R burgdorferi isolated from
the peripheral bloodand synovial fluidof patients with chronic
Lyme arthritis. In contrast to results obtained from ex-
perimental animal models of inflammatory diseases, where
it was found that the pathogenic T cells were oligoclonally
derived (1, 2), our data indicate that there is diversity in T
cellsresponding to spirochetal antigens in Lyme arthritis pa-
tients. This diversity is reflected in the many spirochetal an-
tigens recognized by Borrelia-reactive T cell clones, theirutili-
zation ofTCR variable region gene segments, as well as the
multiple HLA class II alleles involved in the recognition of
spirochetal antigens. Detailed analysis of the cloned CD4+
T cellsreactive with myelinbasic protein (25) and the acetyl-
choline receptor (26) isolated from patients with multiple
sclerosis or myasthenia gravis, respectively, have also indicated
that there is heterogeneity in the responding T cells. The
increased heterogeneity noted in the human T cell response
Table 3.
￿
Lymphokine Production by Human T Cell Clones Reactive with B. burgdoferi Antigens, Tetanus Toxoid, Alloantigen,
or of Undetermined Antigenic Specificity.
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to antigen, relative to that of the inbred animal strains, may
partially result from the increased number of distinct HLA
class II proteins found on human cells. There are six, and
in certain haplotypes eight, distinct HLA class II antigens
expressed on human APC, while the APC of inbred mouse
or rat strains have at most two distinct alleles (27). The demon-
stration that multiple distinct HLA class II proteins can present
spirochetal antigens to human T cells is consistent with the
absence of an immunogenetic association with susceptibility
to development of arthritis among patients with Lyme dis-
ease (28) . The chronicity of antigen exposure may also be
another factor contributing to the diversity of the human
T cell response. Experimental animals are often evaluated a
short time afterdisease initiation, while human diseases may
become clinically apparent many months to years after the
inciting event.
Despite the lack ofclonal restriction and their recognition
of distinct antigens, all of the spirochete-reactive T cell clones
exhibited the same restricted profile of lymphokine produc-
tion. CD4+ T cells in the mouse have been divided into two
distinct subsets, basedon the pattern oflymphokines secreted
(reviewed in reference 29). One subset, referred to as Thl
cells, produces IL-2 and IFN-y upon activation and mediates
delayed type hypersensitivity. A second subset, type 2 helper
T cells (Th2) secretes IL4 and ILS, and supports antibody
productionby B cells. Initially, it did not appear that human
CD4+ T cells could be separated into Thl and Th2 cell
types. Two studies, examining large panels of cloned human
T cells isolated from peripheral blood and lymphoid organs
(148-4,198) (129-2,374)
Lymphokine-containing supernatants were prepared from cloned T cells stimulated with 10 gg/ml Con A for 12-18 h. The amount of IL-4, IL-5,
or IFN-y in the supernatants was determined using cytokine-specific ELISAs as described in Table 2. The numbers indicate the mean and SD for
the amount of each lymphokine produced by T cell clones prepared from the indicated donor. The range of values obtained are indicated by the
numbers in parenthesis. A dash indicates data that are not available.
Donor No. of clones Specificity IFN-y
ng/ml
IL-4
pg/ml
IL-5
pg/ml
Control 1 5 Alloreactive 3.4 ± 1 260 ± 195 -
(2-5) (200-550)
2 23 Unknown 5.3 ± 3 1,255 ± 1,515
(1-10) (<50-9,600)
3 5 Tetanus toxoid 54 ± 45 815 ± 850
(4-124) (200-2,500)
4 5 Tetanus toxoid 25 ± 24 3,250 ± 3,605 627 ± 667
(6-68) (220-7,800) (149-1,742)
Lyme CR 5 B. burdorferi 16 ± 7 <50 <50
arthritis (5 .7-25)
CR 5 Tetanus toxoid 1,825 ± 1,668 995 ± 831of normal individuals without allergic or chronic inflamma-
tory diseases, failed to demonstrate clonal segregation in lym-
phokine gene expression similar to that ofmurineT cell clones
(30, 31) . The majority of mature human T cells produced
effector lymphokines characteristic ofboth Thl andTh2 cell
subsets . In addition, it had been demonstrated that after acti-
vation, human T lymphocytes undergo a functional differen-
tiation, acquiring the ability to produce effector cytokines
characteristic of both Thl and Th2 cells (32, 33) .
The significance of our finding that the Borrelia-reactive
T cell clones produce a Thl-like pattern of cytokine produc-
tion is underscored by the above data . Presumably, the
spirochete-reactive T cell clones represent T cells that have
been repetitively stimulated by antigen in vivo, a process that
may be required before the T cells acquire a restricted profile
oflymphokine secretion . In support ofthis, allergen-specific
human T cell clones isolated from atopic patients, apparently
repeatedly exposed to the allergen, have also been shown to
exhibit a restricted profile of lymphokine secretion (34 ; H .
Yssel, et al ., manuscript submitted for publication) .
It should also be emphasized that a substantial number
of control experiments were performed to ensure that these
results are not due to a bias in the methodology used to
generate theT cell clones . Identical procedures have been used
to produce cloned T cell lines reactive with tetanus toxin,
from the Lyme arthritis patients as well as healthy individ-
uals, which produce 114, ILS, and IFN-y, as well as other
cytokines . In addition, allergen-specificT cell clones isolated
from atopic patients using the same methodology produced
exceedingly high levels of IL4 and IL-5 upon activation (H.
Yssel et al ., manuscript submitted for publication) . There-
fore, the finding that a relatively large number of Borrelia-
reactive clonedT cells (recognizing a diverse array ofspirochetal
antigens and obtained from four different Lyme arthritis pa-
tients) were all unable to secrete 11,4 or IIr5 suggests that
this specific pattern of lymphokine production may be
spirochete induced. The mechanism through which the
spirochete selectively activates Thl-like T cells is unknown
at present . The fact that the spirochete-reactive T cells ex-
press different TCRs and recognize different antigens indi-
cates that their pattern oflymphokine production is not the
result of selection in the thymus, nor is it determined by a
particular epitope .
These findings demonstrate that a human CD4+ T cell
subset with a specific pattern oflymphokine secretion exists,
and can be selectively activated by a pathogen inciting a chronic
inflammatory disease . The selective activation of this T cell
subset is likely to play a role in the pathogenesis of chronic
inflammation in this and other inflammatory diseases . The
importance ofthe production ofdistinct lymphokines through
selective activation of CD4+ T cell subsets in the immune
response to infectious agents has been demonstrated in ex-
perimental murine leishmaniasis (35) . Although it may be
advantageous to mount a Thl-like T cell response in con-
trolling infection by an intracellular pathogen such asL . major
or a virus, this seems not to be effective against an extracel-
lular pathogen like R burgdorferi (reviewed in reference 29) .
It has previously been demonstrated in mice that protection
against R burgdorfM infection requires the generation of
complement-fixing antibodies directed against certain spiro-
chetal antigens (36) . Therefore, we propose that the selective
activation ofThl-likeT cells, which do not efficiently stimulate
antibody production byB cells, may be a mechanism by which
the spirochete can avoid elimination by the host immune re-
sponse. The continuous production of Thl-like cytokines by
Borrelia-reactive T cells, unable to eliminate the pathogen,
is likely to induce and maintain a state ofinflammation within
the target tissue . TNF-a has been shown to stimulate carti-
lage and bone resorption (reviewed in reference 37), while
IFN-y andGM-CSF induce expression ofHLA class II mol-
ecules onhuman monocytes (38) . However, additional studies
will have to be performed to directly demonstrate that the
selective activation of Thl-likeT cells by spirochetal antigen
plays a role in the pathogenesis of human Lyme disease.
It is likely that the arthritic potential ofB burgdorferi in
humans results from both its ability to selectively activate
Thl-like T cells, as well as its tropism for articular tissue.
With time, an infected individual will develop a cellular im-
mune response against a number ofdifferent spirochetal an-
tigens. The presence of spirochetal antigens in articular tissue,
one or more ofwhichmay have affinity for connective tissue
components (39), activates Thl-like T cells leading to an
inflammatory synovitis. Each of the CD4+ T cell subsets
produce factors that inhibit the growth or differentiation of
the other (reviewed in reference 40) . Therefore, the selective
activation ofThl cells by spirochetal antigen, in the absence
of the regulatory signals from Th2 cells, contributes to the
development of synovial inflammation . Although this model
may explain some of the early events in the pathogenesis of
inflammatory synovitis, it does not explain why a minority
of individuals infected with withR burgdorferi will develop
a chronic arthritis (12, 13) . Other factors such as the HLA
haplotype (28) or the status of the immune system (41, 42)
were thought to determine whether the immune response
of an infected individual will control the infection with little
inflammatory tissue injury, or contribute to the development
of a chronic destructive arthritis . We propose that the proba-
bility that an individual will develop an inflammatory or al-
lergic disease in response to exposure to a pathogen or al-
lergen may be determined by the type of CD4+ T cell that
dominates the response to the antigen. Immune-mediated dis-
easemay develop if the cellular response becomes pathologi-
cally fixed in a Thl or Th2 mode, while a balanced response,
or a response dominated by the appropriate subset, will be
protective and not have pathologic consequences.
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